Popular Filters
Trials for Melanoma Patients
CAR T-cell Therapy
NK Cell Therapy + Temozolomide for Melanoma with Brain Metastasis
Recruiting1 awardPhase 1 & 2
Columbus, Ohio
This trial is testing a combination of special immune cells and a cancer drug to treat patients with advanced melanoma that has spread to the brain. The immune cells aim to kill the cancer, and the drug helps stop its growth. A new treatment has shown effectiveness against advanced melanoma and brain involvement.
Monoclonal Antibodies
Sarilumab + Immunotherapy for Melanoma
Recruiting2 awardsPhase 2
Los Angeles, California
This trial tests a combination of drugs, including one usually for arthritis and three for cancer. It targets patients with advanced melanoma that can't be surgically removed. The drugs help the immune system attack the cancer by blocking proteins that help the cancer grow.
Monoclonal Antibodies
Triple Drug Therapy for Melanoma
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a combination of three drugs to treat melanoma. The drugs will be given for different lengths of time depending on whether the patient is in the induction or maintenance phase of the trial. The trial will assess the safety and tolerability of the combination and the pharmacodynamic activity of one of the drugs.
Chemotherapy
Ipilimumab + Chemotherapy for Melanoma
Recruiting3 awardsPhase 2
Montreal, Quebec
This trial will study the safety of combining the drugs ipilimumab and carboplatin/paclitaxel to treat metastatic melanoma. It will also look at whether the combination can help patients and what features of the immune system may predict who will respond to the treatment.
Trials for Skin Cancer Patients
CAR T-cell Therapy
NK Cell Therapy + Temozolomide for Melanoma with Brain Metastasis
Recruiting1 awardPhase 1 & 2
Columbus, Ohio
This trial is testing a combination of special immune cells and a cancer drug to treat patients with advanced melanoma that has spread to the brain. The immune cells aim to kill the cancer, and the drug helps stop its growth. A new treatment has shown effectiveness against advanced melanoma and brain involvement.
Monoclonal Antibodies
Sarilumab + Immunotherapy for Melanoma
Recruiting2 awardsPhase 2
Los Angeles, California
This trial tests a combination of drugs, including one usually for arthritis and three for cancer. It targets patients with advanced melanoma that can't be surgically removed. The drugs help the immune system attack the cancer by blocking proteins that help the cancer grow.
Monoclonal Antibodies
Triple Drug Therapy for Melanoma
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a combination of three drugs to treat melanoma. The drugs will be given for different lengths of time depending on whether the patient is in the induction or maintenance phase of the trial. The trial will assess the safety and tolerability of the combination and the pharmacodynamic activity of one of the drugs.
Trials for Metastatic Patients
CAR T-cell Therapy
NK Cell Therapy + Temozolomide for Melanoma with Brain Metastasis
Recruiting1 awardPhase 1 & 2
Columbus, Ohio
This trial is testing a combination of special immune cells and a cancer drug to treat patients with advanced melanoma that has spread to the brain. The immune cells aim to kill the cancer, and the drug helps stop its growth. A new treatment has shown effectiveness against advanced melanoma and brain involvement.
Monoclonal Antibodies
Sarilumab + Immunotherapy for Melanoma
Recruiting2 awardsPhase 2
Los Angeles, California
This trial tests a combination of drugs, including one usually for arthritis and three for cancer. It targets patients with advanced melanoma that can't be surgically removed. The drugs help the immune system attack the cancer by blocking proteins that help the cancer grow.
Monoclonal Antibodies
Triple Drug Therapy for Melanoma
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a combination of three drugs to treat melanoma. The drugs will be given for different lengths of time depending on whether the patient is in the induction or maintenance phase of the trial. The trial will assess the safety and tolerability of the combination and the pharmacodynamic activity of one of the drugs.
Chemotherapy
Ipilimumab + Chemotherapy for Melanoma
Recruiting3 awardsPhase 2
Montreal, Quebec
This trial will study the safety of combining the drugs ipilimumab and carboplatin/paclitaxel to treat metastatic melanoma. It will also look at whether the combination can help patients and what features of the immune system may predict who will respond to the treatment.
Trials With No Placebo
CAR T-cell Therapy
NK Cell Therapy + Temozolomide for Melanoma with Brain Metastasis
Recruiting1 awardPhase 1 & 2
Columbus, Ohio
This trial is testing a combination of special immune cells and a cancer drug to treat patients with advanced melanoma that has spread to the brain. The immune cells aim to kill the cancer, and the drug helps stop its growth. A new treatment has shown effectiveness against advanced melanoma and brain involvement.
Monoclonal Antibodies
Sarilumab + Immunotherapy for Melanoma
Recruiting2 awardsPhase 2
Los Angeles, California
This trial tests a combination of drugs, including one usually for arthritis and three for cancer. It targets patients with advanced melanoma that can't be surgically removed. The drugs help the immune system attack the cancer by blocking proteins that help the cancer grow.
Monoclonal Antibodies
Triple Drug Therapy for Melanoma
Recruiting1 awardPhase 2
Los Angeles, California
This trial is testing a combination of three drugs to treat melanoma. The drugs will be given for different lengths of time depending on whether the patient is in the induction or maintenance phase of the trial. The trial will assess the safety and tolerability of the combination and the pharmacodynamic activity of one of the drugs.
Chemotherapy
Ipilimumab + Chemotherapy for Melanoma
Recruiting3 awardsPhase 2
Montreal, Quebec
This trial will study the safety of combining the drugs ipilimumab and carboplatin/paclitaxel to treat metastatic melanoma. It will also look at whether the combination can help patients and what features of the immune system may predict who will respond to the treatment.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.